← Leaderboards
David Powell
Rand Corporation
$4,656,521
Attributed
$5,127,260
Total exposure
8
Grants
7
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.1M · FY2014–25$2M$1.5M$1M$500K$0
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$3,101,585 · 6
CDC$1,929,148 · 1
AHRQ$96,527 · 1
By mechanism
R21$2,160,130 · 5
R01$1,929,148 · 1
P50$941,455 · 1
R03$96,527 · 1
Top collaborators
- Rahi Abouk2 shared
- Evan David Peet2 shared
Most similar at Rand Corporation
Same institution · by research overlap
- Andrew W Mulcahy$400,000
- Rahi Abouk$231,657
- Evan David Peet$2,450,562
Others in their field
Top investigators on “Overdose”
- Sharon L. Walsh · University Of Kentucky$91,520,716
- Jeffrey H Samet · Boston University Medical Campus$88,233,622
- T John Winhusen · University Of Cincinnati$57,469,042
- Edward V Nunes · Columbia University Health Sciences$38,602,788
- Yasmin L Hurd · Icahn School Of Medicine At Mount Sinai$32,706,021
- Rebecca D Jackson · Ohio State University$29,698,788
Research focus
OverdosePoliciesPrescription OpioidAffectPublic HealthOpioidPharmaceutical PreparationsMortalityHeroinTrendPrescription Monitoring ProgramVariantBaseAdoptionResearch PersonnelOpioid PolicyAreaHeroin AbuseOpioid EpidemicHeterogeneityFentanylFederal PolicyCessation Of LifePrescription Opioid Misuse
Grant awards (18)
Understanding cannabidiol policy and its impacts on broader substance use$268,470
R21 · FY2025 · DA · contact PI
A National Survey on Naloxone Use and Access$424,545
R21 · FY2024 · DA · contact PI
Measuring the Presence of Opioid Markets in Local Communities and Their Impacts on Harm$218,230
P50 · FY2022 · DA · contact PI
Changes to which Drugs and Drug Combinations are Prescribed in Response to Opioid Supply-side Policies$195,828
R21 · FY2022 · DA
Changes to which Drugs and Drug Combinations are Prescribed in Response to Opioid Supply-side Policies$282,338
R21 · FY2021 · DA
Measuring the Presence of Opioid Markets in Local Communities and Their Impacts on Harm$192,498
P50 · FY2021 · DA · contact PI
Improving Naloxone Access and Its Effects on Drug Abuse and Overdoses$636,614
R01 · FY2020 · CE · contact PI
Can Mandatory Electronic Prescriptions Reduce Opioid Abuse?$203,848
R21 · FY2020 · DA · contact PI
Measuring the Presence of Opioid Markets in Local Communities and Their Impacts on Harm$185,936
P50 · FY2020 · DA · contact PI
Improving Naloxone Access and Its Effects on Drug Abuse and Overdoses$629,888
R01 · FY2019 · CE · contact PI
Can Mandatory Electronic Prescriptions Reduce Opioid Abuse?$259,465
R21 · FY2019 · DA · contact PI
Measuring the Presence of Opioid Markets in Local Communities and Their Impacts on Harm$183,476
P50 · FY2019 · DA · contact PI
Improving Naloxone Access and Its Effects on Drug Abuse and Overdoses$662,646
R01 · FY2018 · CE · contact PI
Prescription Drug Coverage, Access to Opioids, and Drug Abuse$237,238
R21 · FY2018 · DA · contact PI
Measuring the Presence of Opioid Markets in Local Communities and Their Impacts on Harm$161,315
P50 · FY2018 · DA · contact PI
Prescription Drug Coverage, Access to Opioids, and Drug Abuse$288,398
R21 · FY2017 · DA · contact PI
How Will the Cadillac Tax Affect Private Insurance Plans?$48,527
R03 · FY2015 · HS · contact PI
How Will the Cadillac Tax Affect Private Insurance Plans?$48,000
R03 · FY2014 · HS · contact PI